The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke

(2013) Joseph P. Broderick et al.   NEW ENGLAND JOURNAL OF MEDICINE

An Observational Study of Thrombolysis Outcomes in Wake-Up Ischemic Stroke Patients

(2013) Dulka Manawadu et al.   STROKE

Endovascular Acute Stroke Treatment Performed by Vascular Interventional Radiologists: Is It Safe and Efficacious?

(2012) Lars Fjetland et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity

(2012) J Parcq et al.   CELL DEATH AND DIFFERENTIATION

A Randomized Trial of Tenecteplase versus Alteplase for Acute Ischemic Stroke

(2012) Mark Parsons et al.   NEW ENGLAND JOURNAL OF MEDICINE

DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study

(2011) Götz Thomalla et al.   LANCET NEUROLOGY

Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR

(2010) Niaz Ahmed et al.   LANCET NEUROLOGY

Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke

(2010) E. Clarke Haley et al.   STROKE

Novel Thrombolytic Drugs

(2009) Atte Meretoja et al.   CNS DRUGS

Acute ischemic stroke: Imaging-guided tenecteplase treatment in an extended time window

(2009) M. W. Parsons et al.   NEUROLOGY

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abstracts From the 2008 International Stroke Conference

(2008)   STROKE

Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic

(2008) Manuel Yepes et al.   TRENDS IN NEUROSCIENCES